Denmark-based diabetes device dev RSP Systems said today it raised approximately $7.6 million (EU €6.5 million) in a Series B round to support its non-invasive glucose monitor technology.
Funds raised in the round will help support clinical trials, pursuit of regulatory approval and eventual commercialization for its glucose monitoring technology.
Read the whole story on our sister site Drug Delivery Business
The post Non-invasive glucose monitor dev RSP Systems raises $8m in Series B appeared first on MassDevice.
from MassDevice https://ift.tt/2sQH2kv
Cap comentari:
Publica un comentari a l'entrada